UNIGE document Scientific Article
previous document  unige:7505  next document
add to browser collection

Infective endocarditis and glycopeptides

Harding, I.
Published in Journal of Infection. 1998, vol. 37, no. 2, p. 127-135
Abstract BACKGROUND: Despite the number of antibacterial agents currently available, endocarditis remains a difficult disease to treat and the mortality rate has not fallen in recent years. The glycopeptides have good activity against the Gram-positive bacteria commonly implicated in endocarditis (staphylococci, both coagulase-positive and negative; enterococci and streptococci). OBJECTIVES: To assess the impact of the glycopeptides vancomycin and teicoplanin on the therapy of infectious endocarditis caused by Gram-positive bacteria. METHODS: A retrospective review of all major published or recently conducted studies using vancomycin or teicoplanin to treat endocarditis. RESULTS: Cure rates obtained with vancomycin and teicoplanin are similar, but there are no controlled studies to investigate this. Vancomycin nephrotoxicity limits its use in endocarditis, in particular when used in combination with an aminoglycoside. By contrast, teicoplanin shows little nephrotoxic potential, even in patients with some degree of renal impairment or when given in combination with an aminoglycoside. Teicoplanin should be used at doses of 6 mg/kg/day or higher to achieve satisfactory cure rates. CONCLUSIONS: Clinical data on the use of glycopeptides in endocarditis suffer from a lack of controlled trials. Although teicoplanin appears to offer some advantages over vancomycin in the therapy of endocarditis, there is an urgent need for randomized, clinical trials before definitive conclusions can be drawn.
Keywords Anti-Bacterial Agents/ therapeutic useClinical Trials as TopicEndocarditis, Bacterial/ drug therapy/microbiologyGram-Positive Bacterial Infections/ drug therapyHumansRetrospective StudiesTeicoplanin/ therapeutic useVancomycin/ therapeutic use
PMID: 9821086
Full text
Article - document accessible for UNIGE members only Limited access to UNIGE
Research group Staphylocoques dorés résistants à la méthicilline et hygiène hospitalière (330)
(ISO format)
PITTET, Didier, HARDING, I. Infective endocarditis and glycopeptides. In: Journal of Infection, 1998, vol. 37, n° 2, p. 127-135. https://archive-ouverte.unige.ch/unige:7505

449 hits

0 download


Deposited on : 2010-06-21

Export document
Format :
Citation style :